Cullinan Therapeutics, Inc.

CGEMNASDAQHealthcare● Active

$13.09

$-0.42(-3.08%)

Market Cap$804761781

P/E Ratio—

52W High$16.74

52W Low$5.68

Avg Volume884K

Open$13.72

Beta0.01

Overview

Cullinan Therapeutics, Inc. (CGEM) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CGEM · net income · updated Jun 8, 2026

Core profitability metrics

CGEM · net income · margin · TTM · CAGR

Net income was −$219.9M for FY2025 (fiscal year ending 2025-12-31), down 31.4% year-over-year. Net profit margin was —. Based on available data, Cullinan Therapeutics, Inc. has been profitable since at least 2022.

FY2025 Net Income−$219.9M▼ -31.4% YoY

Trailing 12M (TTM)−$221.0Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-31.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2022

▸ FMP /income-statement · Annual · CGEM net income history · CGEM profit margin

Annual net income data

CGEM · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$219.9M▼ 31.4%—$0

FY2024Loss−$167.4M▼ 9.3%—$0

FY2023Loss−$153.2M▼ 237.7%—$0

FY2022★ First Profit$111.2M▲ +269.6%—$0

FY2021Loss−$65.6M▼ 26.6%-346.1%$18.9M

Net income vs peers (Healthcare)

CGEM vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Cullinan Therapeutics, Inc.YOU

CGEM

−$219.9M-31.4%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Cullinan Therapeutics, Inc. (CGEM) reported net income of −$219.9M for FY2025 (fiscal year ending 2025-12-31), down 31.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Cullinan Therapeutics, Inc. has been profitable since at least 2022. Net income reached a peak of $111.2M in FY2022. Data available for 8 fiscal years.

Cullinan Therapeutics, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Cullinan Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from CGEM net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CGEM net income · 4 questions

Cullinan Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $219.9M for FY2025.

is CGEM profitabledoes CGEM make a profitCGEM profitabilityCGEM profitable company

▸ Source: FMP /income-statement · GAAP · Cullinan Therapeutics, Inc. · Cullinan Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026